Cubist Systematic Strategies, LLC Mersana Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 45,296 shares of MRSN stock, worth $26,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,296

Holding current value

$26,271

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.42 - $2.68 $64,320 - $121,393	45,296 New	45,296 $64,000
Q1 2024 May 15, 2024	BUY	$2.16 - $5.94 $266,731 - $733,512	123,487 Added 106.77%	239,143 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $60,937 - $128,463	54,899 Added 90.36%	115,656 $268,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $133,179 - $491,256	-125,641 Reduced 67.4%	60,757 $77,000
Q2 2023 Aug 14, 2023	SELL	$3.08 - $9.55 $383,592 - $1.19 Million	-124,543 Reduced 40.05%	186,398 $613,000
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $464,844 - $815,801	-116,211 Reduced 27.21%	310,941 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $195,625 - $272,144	34,624 Added 8.82%	427,152 $2.5 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $1.26 Million - $2.18 Million	273,012 Added 228.43%	392,528 $2.65 Million
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $472,797 - $832,390	-166,478 Reduced 58.21%	119,516 $552,000
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $649,570 - $1.15 Million	173,682 Added 154.64%	285,994 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $615,469 - $1.11 Million	112,312 New	112,312 $699,000
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $173,151 - $292,699	-20,228 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $190,568 - $259,304	14,350 Added 244.13%	20,228 $275,000
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $31,385 - $54,366	2,050 Added 53.55%	5,878 $95,000
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $513,569 - $841,412	-30,497 Reduced 88.85%	3,828 $102,000
Q3 2020 Nov 16, 2020	SELL	$16.2 - $25.7 $164,592 - $261,112	-10,160 Reduced 22.84%	34,325 $639,000
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $160,265 - $715,689	30,585 Added 220.04%	44,485 $1.04 Million
Q1 2020 May 15, 2020	BUY	$4.41 - $9.28 $51,508 - $108,390	11,680 Added 526.13%	13,900 $81,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $6.73 $3,084 - $14,314	-2,127 Reduced 48.93%	2,220 $13,000
Q3 2019 Nov 14, 2019	SELL	$1.54 - $4.2 $16,533 - $45,091	-10,736 Reduced 71.18%	4,347 $7,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $3,206 - $5,344	835 Added 5.86%	15,083 $61,000
Q1 2019 May 15, 2019	BUY	$3.51 - $7.3 $31,660 - $65,846	9,020 Added 172.53%	14,248 $75,000
Q4 2018 Feb 14, 2019	BUY	$3.45 - $9.72 $18,036 - $50,816	5,228 New	5,228 $21,000
Q3 2018 Nov 14, 2018	SELL	$10.0 - $19.02 $16,160 - $30,736	-1,616 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.2 - $22.68 $22,947 - $36,650	1,616 New	1,616 $29,000

Others Institutions Holding MRSN

# of Institutions

130

Shares Held

104M

Call Options Held

58.5K

Put Options Held

471K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $56.4M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Mersana Therapeutics, Inc. Transaction History